Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
5.28
-0.47 (-8.17%)
At close: Jun 5, 2026, 4:00 PM EDT
5.38
+0.10 (1.89%)
After-hours: Jun 5, 2026, 7:54 PM EDT

Turn Therapeutics Statistics

Total Valuation

TTRX has a market cap or net worth of $157.28 million. The enterprise value is $152.07 million.

Market Cap157.28M
Enterprise Value 152.07M

Important Dates

The last earnings date was Monday, May 11, 2026, after market close.

Earnings Date May 11, 2026
Ex-Dividend Date n/a

Share Statistics

TTRX has 29.79 million shares outstanding. The number of shares has increased by 5.93% in one year.

Current Share Class 29.79M
Shares Outstanding 29.79M
Shares Change (YoY) +5.93%
Shares Change (QoQ) +3.69%
Owned by Insiders (%) 58.79%
Owned by Institutions (%) 1.61%
Float 10.83M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 25.71
P/TBV Ratio 30.26
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.98.

Current Ratio 2.23
Quick Ratio 2.19
Debt / Equity 0.98
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -129.17% and return on invested capital (ROIC) is -79.70%.

Return on Equity (ROE) -129.17%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) -79.70%
Return on Capital Employed (ROCE) -56.94%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.92M
Employee Count2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 4.06
200-Day Moving Average n/a
Relative Strength Index (RSI) 56.88
Average Volume (20 Days) 63,640

Short Selling Information

The latest short interest is 64,613, so 0.22% of the outstanding shares have been sold short.

Short Interest 64,613
Short Previous Month 51,417
Short % of Shares Out 0.22%
Short % of Float 0.60%
Short Ratio (days to cover) 2.83

Income Statement

Revenue n/a
Gross Profit -974,595
Operating Income -7.69M
Pretax Income -3.84M
Net Income -3.84M
EBITDA -7.64M
EBIT -7.69M
Earnings Per Share (EPS) -$0.14
Full Income Statement

Balance Sheet

The company has $11.22 million in cash and $6.01 million in debt, with a net cash position of $5.21 million or $0.17 per share.

Cash & Cash Equivalents 11.22M
Total Debt 6.01M
Net Cash 5.21M
Net Cash Per Share $0.17
Equity (Book Value) 6.12M
Book Value Per Share 0.21
Working Capital 6.32M
Full Balance Sheet

Cash Flow

Operating Cash Flow -3.90M
Capital Expenditures n/a
Depreciation & Amortization 54,775
Net Borrowing 6.72M
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TTRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.93%
Shareholder Yield -5.93%
Earnings Yield -2.44%
FCF Yield n/a

Analyst Forecast

The average price target for TTRX is $6.77, which is 51.52% higher than the current price. The consensus rating is "Buy".

Price Target $6.77
Price Target Difference 51.52%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a